 | By Fighting Parkinson's Drug Free Howard Shifke knows a thing or two about Parkinson's disease. In his book "Fighting Parkinson's...and Winning: A memoir of my recovery from Parkinson's Disease," Shifke recounts the story of his developing Parkinson's, getting diagnosed, and his daily...
|
By Parkinson's Foundation TheParkinson's Foundation is hosting its Annual Celebrate Spring New Yorkevent, whichwill take place on Wednesday, April 11, 2018 at Lavo located at 39 East 58th Street between Madison and Park Avenues.
|
By Peter Hunt Books "The Lost Intruder, the Search for a Missing Navy Jet" (ISBN 1546334971) relates diver and former Navy pilot Peter M. Hunt's successful search of Puget Sound for an A-6 Intruder while battling Parkinson's disease.
|
By Mary Ann Liebert, Inc., publishers Researchers have demonstrated the ability to generate dopaminergic neurons in the laboratory from induced pluripotent stem cells (iPSCs) derived from fibroblast cells of adult marmoset monkeys.
|
By Biodex Medical Systems, Inc. Enhancing neuroplasticity with pattern sensory-enhanced movement
|
By Biotech Support Group Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for improving the signal from whole blood protein immunoblot analysis. The citation is: Lahut, Suna, et al.
|
By Neurodon LLC Neurodon LLC has recently published a breakthrough study that paves the way for a new, effective way to treat Parkinson's disease. The novel strategy focuses on a process called endoplasmic reticulum stress, or ER stress.
|
By ARS Therapeutics Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone.
|
By Parkinson's Disease Foundation The Young New Yorkers for the Fight Against Parkinson’s and the Parkinson’s Disease Foundation® (PDF®) will hold its ninth annual Celebrate Spring New York at Marquee located at 289 10th Avenue between 26th and 27th Streets in New York City on...
|
By Neurolixis, Inc. Neurolixis, Inc. announced the recent publication of two scientific articles demonstrating robust effects of the Company’s lead drug candidate, NLX-112, in rodent models of Parkinson’s disease.
|
By Parkinson's Disease Foundation On Wednesday, May 11, 2016, the Parkinson’s Disease Foundation® (PDF®) will hold its annual Bal du Printemps Gala at The Metropolitan Club in New York City.
|
 | By Parkinson's Institute and Clinical Center Parkinson's Institute in Sunnyvale, CA, launches mobile health technology device pilot program
|
